focus -WSS

focus

author：leisure time 2025-10-01 22:17:03 - browse：38651

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Midwives could help bridge maternal health disparities in the U.S.

Wikipedia

WSS

Neurocrine congenital adrenal hyperplasia trial succeeds

Children’s Hospital revives plan for pedestrian bridge

'Vaccine

PBMs drew scrutiny in House hearing — and so did pharma

Childhood vaccination ad campaign launches in the U.K.

Pfizer is about to make a big push in cancer. Will investors listen?

focus

focus

entertainment

Medical leaders decry Supreme Court decision on affirmative action

Chamber of Commerce, DOJ clash in court over drug prices

Medicare proposal to cover medical devices draws a mixed reaction

Covid’s new normal has set in amid another rise in cases

In age of alternative facts, a scholarly course on calling out crap

Virtual repurposing can help discover new uses for existing drugs

Medicare details structure of new drug price negotiation program

5 ways to address the shortage of health care workers

Hepatitis C has a cure — but many Americans still lack access to it

Redefining sustainability for the pharmaceutical industry

hotspot

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

David Liu startup to focus on CRISPR delivery

Childhood vaccination ad campaign launches in the U.K.

STAT Madness 2024: Meet the contenders

PBMs drew scrutiny in House hearing — and so did pharma

Information blocking fines are now fair game in health care

Wikipedia

explore

knowledge

entertainment